Gsa Capital Partners LLP Embecta Corp. Transaction History

Gsa Capital Partners LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$10.13 - $14.6 $410,629 - $591,825	40,536 New	40,536 $507,000
Q3 2023 Nov 15, 2023	BUY	$15.0 - $22.17 $107,505 - $158,892	7,167 Added 20.2%	42,641 $641,000
Q2 2023 Aug 14, 2023	BUY	$21.6 - $30.69 $448,286 - $636,940	20,754 Added 140.99%	35,474 $766,000
Q1 2023 May 12, 2023	BUY	$23.07 - $32.77 $339,590 - $482,374	14,720 New	14,720 $413,000

405

51.1M

162K

61K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $1.17B
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.